The DOI matches its Crossref record; 243 of the 243 references it cites were found in a registry or an index.
Targeting cell cycle regulation in cancer therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
The metabolism of tumors in the body
Warburg, O., Wind, F., & Negelein, E. (1927) · Journal of General Physiology · doi:10.1085/jgp.8.6.519 · Cited by 4,416
Microtubules as a target for anticancer drugs
Jordan, M. A., & Wilson, L. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1317 · Cited by 4,000
Cell cycle, CDKs and cancer: a changing paradigm
Malumbres, M., & Barbacid, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2602 · Cited by 3,957
ROS as signalling molecules: Mechanisms that generate specificity in ROS homeostasis
D'Autréaux, B., & Toledano, M. B. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2256 · Cited by 3,642
Blinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
Checkpoints: Controls That Ensure the Order of Cell Cycle Events
Hartwell, L. H., & Weinert, T. A. (1989) · Science · doi:10.1126/science.2683079 · Cited by 3,021
Cell-cycle checkpoints and cancer
Kastan, M. B., & Bartek, J. (2004) · Nature · doi:10.1038/nature03097 · Cited by 2,836
G1 phase progression: Cycling on cue
Sherr, C. J. (1994) · Cell · doi:10.1016/0092-8674(94)90540-1 · Cited by 2,674
Cyclin is degraded by the ubiquitin pathway
Glotzer, M., Murray, A. W., & Kirschner, M. W. (1991) · Nature · doi:10.1038/349132a0 · Cited by 2,357
Tumor cell metabolism: cancer's Achilles' heel
Kroemer, G., & Pouyssegur, J. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.005 · Cited by 2,337
CYCLIN-DEPENDENT KINASES: Engines, Clocks, and Microprocessors
Morgan, D. O. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.261 · Cited by 2,259
Farber, S., Diamond, L. K., Mercer, R. D., Sylvester, R. F., & Wolff, J. A. (1948) · New England Journal of Medicine · doi:10.1056/nejm194806032382301 · Cited by 1,806
AMP-activated protein kinase induces a p53-dependent metabolic checkpoint
Jones, R. G., Plas, D. R., Kubek, S., Buzzai, M., Mu, J., Xu, Y., Birnbaum, M. J., & Thompson, C. B. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.027 · Cited by 1,619
Hydrogen peroxide sensing and signaling
Veal, E. A., Day, A. M., & Morgan, B. A. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.03.016 · Cited by 1,604
Fluorinated pyrimidines, a new class of tumour-inhibitory compounds
HEIDELBERGER, C., CHAUDHURI, N. K., DANNEBERG, P., MOOREN, D., GRIESBACH, L., DUSCHINSKY, R., SCHNITZER, R. J., PLEVEN, E., & SCHEINER, J. (1957) · Nature · doi:10.1038/179663a0 · Cited by 1,603
Chk1 and Chk2 kinases in checkpoint control and cancer
Bartek, J., & Lukas, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00110-7 · Cited by 1,513
To cycle or not to cycle: a critical decision in cancer
Malumbres, M., & Barbacid, M. (2001) · Nature Reviews Cancer · doi:10.1038/35106065 · Cited by 1,468
Ubiquitin ligases: cell-cycle control and cancer
Nakayama, K. I., & Nakayama, K. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1881 · Cited by 1,433
A Restriction Point for Control of Normal Animal Cell Proliferation
Pardee, A. B. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.4.1286 · Cited by 1,415
Meijer, L., Borgne, A., Mulner, O., Chong, J. P. J., Blow, J. J., Inagaki, N., Inagaki, M., Delcros, J., & Moulinoux, J. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.t01-2-00527.x · Cited by 1,352
The anaphase promoting complex/cyclosome: a machine designed to destroy
Peters, J.-M. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1988 · Cited by 1,315
Mammalian cyclin-dependent kinases
Malumbres, M., & Barbacid, M. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.09.005 · Cited by 1,295
ANIMAL CELL CYCLES AND THEIR CONTROL
Norbury, C., & Nurse, P. (1992) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.61.070192.002301 · Cited by 1,274
Bond, G. L., Hu, W., Bond, E. E., Robins, H., Lutzker, S. G., Arva, N. C., Bargonetti, J., Bartel, F., Taubert, H., Wuerl, P., et al. (2004) · Cell · doi:10.1016/j.cell.2004.11.022 · Cited by 1,265
G1 cell-cycle control and cancer
Massagué, J. (2004) · Nature · doi:10.1038/nature03094 · Cited by 1,224
Radical-free biology of oxidative stress
Jones, D. P. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00283.2008 · Cited by 1,213
On the road to cancer: aneuploidy and the mitotic checkpoint
Kops, G. J. P. L., Weaver, B. A. A., & Cleveland, D. W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1714 · Cited by 1,185
The Rb/E2F pathway: expanding roles and emerging paradigms
Harbour, J. W., & Dean, D. C. (2000) · Genes & Development · doi:10.1101/gad.813200 · Cited by 1,153
Reactive Oxygen Species as Intracellular Messengers During Cell Growth and Differentiation
Sauer, H., Wartenberg, M., & Hescheler, J. (2001) · Cellular Physiology and Biochemistry · doi:10.1159/000047804 · Cited by 1,118
The SCF ubiquitin ligase: insights into a molecular machine
Cardozo, T., & Pagano, M. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1471 · Cited by 1,114
Cdk1 is sufficient to drive the mammalian cell cycle
Santamaría, D., Barrière, C., Cerqueira, A., Hunt, S., Tardy, C., Newton, K., Cáceres, J. F., Dubus, P., Malumbres, M., & Barbacid, M. (2007) · Nature · doi:10.1038/nature06046 · Cited by 1,114
ATP citrate lyase inhibition can suppress tumor cell growth
Hatzivassiliou, G., Zhao, F., Bauer, D. E., Andreadis, C., Shaw, A. N., Dhanak, D., Hingorani, S. R., Tuveson, D. A., & Thompson, C. B. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.09.008 · Cited by 1,086
Cyclin-Dependent Kinase Pathways As Targets for Cancer Treatment
Shapiro, G. I. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.7689 · Cited by 1,036
Vousden, K. H., & Ryan, K. M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2715 · Cited by 959
Specific protection against breast cancers by cyclin D1 ablation
Yu, Q., Geng, Y., & Sicinski, P. (2001) · Nature · doi:10.1038/35082500 · Cited by 934
A family of human cdc2-related protein kinases.
Meyerson, M., Enders, G. H., Wu, C. L., Su, L. K., Gorka, C., Nelson, C., Harlow, E., & Tsai, L. H. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05360.x · Cited by 923
Cyclin E-CDK2 is a regulator of p27Kip1.
Sheaff, R. J., Groudine, M., Gordon, M., Roberts, J. M., & Clurman, B. E. (1997) · Genes & Development · doi:10.1101/gad.11.11.1464 · Cited by 911
The Anaphase-Promoting Complex
Peters, J.-M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00540-3 · Cited by 909
Cell cycle kinases as therapeutic targets for cancer
Lapenna, S., & Giordano, A. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2907 · Cited by 905
Logic of the Yeast Metabolic Cycle: Temporal Compartmentalization of Cellular Processes
Tu, B. P., Kudlicki, A., Rowicka, M., & McKnight, S. L. (2005) · Science · doi:10.1126/science.1120499 · Cited by 901
Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis
Holland, A. J., & Cleveland, D. W. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2718 · Cited by 859
Herrero-Mendez, A., Almeida, A., Fernández, E., Maestre, C., Moncada, S., & Bolaños, J. P. (2009) · Nature Cell Biology · doi:10.1038/ncb1881 · Cited by 844
Lost in Transcription: p21 Repression, Mechanisms, and Consequences
Gartel, A. L., & Radhakrishnan, S. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3995 · Cited by 818
Chromosomal passengers: conducting cell division
Ruchaud, S., Carmena, M., & Earnshaw, W. C. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2257 · Cited by 811
Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice
Ortega, S., Prieto, I., Odajima, J., Martín, A., Dubus, P., Sotillo, R., Barbero, J. L., Malumbres, M., & Barbacid, M. (2003) · Nature Genetics · doi:10.1038/ng1232 · Cited by 796
p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase
Jiang, P., Du, W., Wang, X., Mancuso, A., Gao, X., Wu, M., & Yang, X. (2011) · Nature Cell Biology · doi:10.1038/ncb2172 · Cited by 795
Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6
Malumbres, M., Sotillo, R., Santamarı́a, D., Galán, J., Cerezo, A., Ortega, S., Dubus, P., & Barbacid, M. (2004) · Cell · doi:10.1016/j.cell.2004.08.002 · Cited by 793
Wolf, A., Agnihotri, S., Micallef, J., Mukherjee, J., Sabha, N., Cairns, R., Hawkins, C., & Guha, A. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101470 · Cited by 789
Cyclin D-dependent kinases, INK4 inhibitors and cancer
Ortega, S., Malumbres, M., & Barbacid, M. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00037-9 · Cited by 778
The KEN box: an APC recognition signal distinct from the D box targeted by Cdh1
Pfleger, C. M., & Kirschner, M. W. (2000) · Genes & Development · doi:10.1101/gad.14.6.655 · Cited by 732
Berthet, C., Aleem, E., Coppola, V., Tessarollo, L., & Kaldis, P. (2003) · Current Biology · doi:10.1016/j.cub.2003.09.024 · Cited by 663
MDM2 — master regulator of the p53 tumor suppressor protein
Momand, J., Wu, H.-H., & Dasgupta, G. (2000) · Gene · doi:10.1016/s0378-1119(99)00487-4 · Cited by 641
Mitra, K., Wunder, C., Roysam, B., Lin, G., & Lippincott-Schwartz, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904875106 · Cited by 633
�ber den Stoffwechsel der Carcinomzelle
Warburg, O. (1924) · Die Naturwissenschaften · doi:10.1007/bf01504608 · Cited by 631
Shangary, S., & Wang, S. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094723 · Cited by 623
A Long Twentieth Century of the Cell Cycle and Beyond
Nurse, P. (2000) · Cell · doi:10.1016/s0092-8674(00)81684-0 · Cited by 618
Increased lipogenesis in cancer cells: new players, novel targets
Swinnen, J. V., Brusselmans, K., & Verhoeven, G. (2006) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000232894.28674.30 · Cited by 610
Orlistat Is a Novel Inhibitor of Fatty Acid Synthase with Antitumor Activity
Kridel, S. J., Axelrod, F., Rozenkrantz, N., & Smith, J. W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3645 · Cited by 607
Bajad, S. U., Lu, W., Kimball, E. H., Yuan, J., Peterson, C., & Rabinowitz, J. D. (2006) · Journal of Chromatography A · doi:10.1016/j.chroma.2006.05.019 · Cited by 592
Kletzien, R. F., Harris, P. K. W., & Foellmi, L. A. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.2.8119488 · Cited by 550
ATP-Citrate Lyase: A Key Player in Cancer Metabolism
Zaidi, N., Swinnen, J. V., & Smans, K. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4112 · Cited by 545
Importance of Glucose-6-phosphate Dehydrogenase Activity for Cell Growth
Tian, W.-N., Braunstein, L. D., Pang, J., Stuhlmeier, K. M., Xi, Q.-C., Tian, X., & Stanton, R. C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10609 · Cited by 532
Cyclin-dependent kinases: a family portrait
Malumbres, M., Harlow, E., Hunt, T., Hunter, T., Lahti, J. M., Manning, G., Morgan, D. O., Tsai, L.-H., & Wolgemuth, D. J. (2009) · Nature Cell Biology · doi:10.1038/ncb1109-1275 · Cited by 495
The anaphase-promoting complex: it's not just for mitosis any more
Harper, J. W., Burton, J. L., & Solomon, M. J. (2002) · Genes & Development · doi:10.1101/gad.1013102 · Cited by 491
Fang, G., Yu, H., & Kirschner, M. W. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80126-4 · Cited by 486
Proliferation of cancer cells despite CDK2 inhibition
Tetsu, O., & McCormick, F. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00053-9 · Cited by 466
Mitotic Regulation of the APC Activator Proteins CDC20 and CDH1
Kramer, E. R., Scheuringer, N., Podtelejnikov, A. V., Mann, M., & Peters, J.-M. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.5.1555 · Cited by 455
Cell cycle regulation by the Cdc25 phosphatase family
Nilsson, I., & Hoffmann, I. (2000) · Progress in Cell Cycle Research · doi:10.1007/978-1-4615-4253-7_10 · Cited by 450
Mitochondrial Regulation of Cell Cycle and Proliferation
Antico Arciuch, V. G., Elguero, M. E., Poderoso, J. J., & Carreras, M. C. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4085 · Cited by 434
Multiple roles of the cell cycle inhibitor p21CDKN1A in the DNA damage response
Cazzalini, O., Scovassi, A. I., Savio, M., Stivala, L. A., & Prosperi, E. (2010) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2010.01.009 · Cited by 433
Requirement for CDK4 kinase function in breast cancer
Yu, Q., Sicinska, E., Geng, Y., Ahnström, M., Zagozdzon, A., Kong, Y., Gardner, H., Kiyokawa, H., Harris, L. N., Stål, O., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2005.12.012 · Cited by 429
Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer
Yalcin, A., Telang, S., Clem, B., & Chesney, J. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2009.01.003 · Cited by 405
Uber den Stoffwechsel der Karzinomezellen
Warburg, O. (1924) · Medical Entomology and Zoology · Cited by 402
Kabashima, T., Kawaguchi, T., Wadzinski, B. E., & Uyeda, K. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730817100 · Cited by 401
FoxM1: At the crossroads of ageing and cancer
Laoukili, J., Stahl, M., & Medema, R. H. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.08.006 · Cited by 377
Cyclin a Is Destroyed in Prometaphase and Can Delay Chromosome Alignment and Anaphase
den Elzen, N., & Pines, J. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.1.121 · Cited by 371
Flaherty, K. T., LoRusso, P. M., DeMichele, A., Abramson, V. G., Courtney, R., Randolph, S. S., Shaik, M. N., Wilner, K. D., O'Dwyer, P. J., & Schwartz, G. K. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0509 · Cited by 366
The cell cycle is a redox cycle: Linking phase-specific targets to cell fate
Burhans, W. C., & Heintz, N. H. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.05.026 · Cited by 361
Glycolysis: a bioenergetic or a survival pathway?
Bolaños, J. P., Almeida, A., & Moncada, S. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.10.006 · Cited by 359
A structural perspective of CTD function
Meinhart, A., Kamenski, T., Hoeppner, S., Baumli, S., & Cramer, P. (2005) · Genes & Development · doi:10.1101/gad.1318105 · Cited by 359
PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2,6-bisphosphate
Okar, D. A., Lange, A. J., Manzano, À., Navarro-Sabatè, A., Riera, L., & Bartrons, R. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01699-6 · Cited by 357
Atg7 Modulates p53 Activity to Regulate Cell Cycle and Survival During Metabolic Stress
Lee, I. H., Kawai, Y., Fergusson, M. M., Rovira, I. I., Bishop, A. J. R., Motoyama, N., Cao, L., & Finkel, T. (2012) · Science · doi:10.1126/science.1218395 · Cited by 355
Rattan, R., Giri, S., Singh, A. K., & Singh, I. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507443200 · Cited by 339
Malumbres, M., & Barbacid, M. (2007) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2006.12.008 · Cited by 338
Zeng, X., Sigoillot, F., Gaur, S., Choi, S., Pfaff, K. L., Oh, D.-C., Hathaway, N., Dimova, N., Cuny, G. D., & King, R. W. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.08.010 · Cited by 333
Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis
Landis, M. W., Pawlyk, B. S., Li, T., Sicinski, P., & Hinds, P. W. (2006) · Cancer Cell · doi:10.1016/j.ccr.2005.12.019 · Cited by 329
Regulation of APC/C Activators in Mitosis and Meiosis
Pesin, J. A., & Orr-Weaver, T. L. (2008) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.041408.115949 · Cited by 321
APC/C and SCF: Controlling Each Other and the Cell Cycle
Vodermaier, H. C. (2004) · Current Biology · doi:10.1016/j.cub.2004.09.020 · Cited by 318
Cyclin C/Cdk3 Promotes Rb-Dependent G0 Exit
Ren, S., & Rollins, B. J. (2004) · Cell · doi:10.1016/s0092-8674(04)00300-9 · Cited by 316
Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma
Leonard, J. P., LaCasce, A. S., Smith, M. R., Noy, A., Chirieac, L. R., Rodig, S. J., Yu, J. Q., Vallabhajosula, S., Schoder, H., English, P., et al. (2012) · Blood · doi:10.1182/blood-2011-10-388298 · Cited by 299
Rocking cell metabolism: revised functions of the key glycolytic regulator PKM2 in cancer
Chaneton, B., & Gottlieb, E. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.04.003 · Cited by 294
The anaphase-promoting complex: a key factor in the regulation of cell cycle
Castro, A., Bernis, C., Vigneron, S., Labbé, J.-C., & Lorca, T. (2005) · Oncogene · doi:10.1038/sj.onc.1207973 · Cited by 292
Evidence that Mitotic Exit Is a Better Cancer Therapeutic Target Than Spindle Assembly
Huang, H.-C., Shi, J., Orth, J. D., & Mitchison, T. J. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.08.020 · Cited by 291
Regulation of reactive oxygen species in stem cells and cancer stem cells
Kobayashi, C. I., & Suda, T. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.22764 · Cited by 286
Ling, Y. H., Liebes, L., Jiang, J. D., Holland, J. F., Elliott, P. J., Adams, J., Muggia, F. M., & Perez-Soler, R. (2003) · PubMed · Cited by 283
Boros, L. G., Puigjaner, J., Cascante, M., Lee, W. N., Brandes, J. L., Bassilian, S., Yusuf, F., Williams, R. D., Muscarella, P., Melvin, W. S., et al. (1997) · PubMed · Cited by 277
Self-citationTranscriptional role of cyclin D1 in development revealed by a genetic-proteomic screen
Bienvenu, F., Jirawatnotai, S., Elias, J. E., Meyer, C. A., Mizeracka, K., Marson, A., Frampton, G. M., Cole, M. F., Odom, D. T., Odajima, J., et al. (2010) · Nature · doi:10.1038/nature08684 · Cited by 276
The Role of p53 in Metabolic Regulation
Puzio-Kuter, A. M. (2011) · Genes & Cancer · doi:10.1177/1947601911409738 · Cited by 273
Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities
He, G., Siddik, Z. H., Huang, Z., Wang, R., Koomen, J., Kobayashi, R., Khokhar, A. R., & Kuang, J. (2005) · Oncogene · doi:10.1038/sj.onc.1208474 · Cited by 264
Langbein, S., Zerilli, M., zur Hausen, A., Staiger, W., Rensch-Boschert, K., Lukan, N., Popa, J., Ternullo, M. P., Steidler, A., Weiss, C., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602962 · Cited by 261
Schwartz, G. K., LoRusso, P. M., Dickson, M. A., Randolph, S. S., Shaik, M. N., Wilner, K. D., Courtney, R., & O'Dwyer, P. J. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.177 · Cited by 260
Redox regulation of the G1 to S phase transition in the mouse embryo fibroblast cell cycle.
Menon, S. G., Sarsour, E. H., Spitz, D. R., Higashikubo, R., Sturm, M. T., Zhang, H., & Goswami, P. C. (2003) · PubMed · Cited by 255
No evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesis
Bluemlein, K., Grüning, N.-M., Feichtinger, R. G., Lehrach, H., Kofler, B., & Ralser, M. (2011) · Oncotarget · doi:10.18632/oncotarget.278 · Cited by 253
Cdk2 suppresses cellular senescence induced by the c-myc oncogene
Campaner, S., Doni, M., Hydbring, P., Verrecchia, A., Bianchi, L., Sardella, D., Schleker, T., Perna, D., Tronnersjö, S., Murga, M., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2004 · Cited by 251
Xiang, X., Saha, A. K., Wen, R., Ruderman, N. B., & Luo, Z. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.06.133 · Cited by 251
Investigating RNA polymerase II carboxyl‐terminal domain (CTD) phosphorylation
Palancade, B., & Bensaude, O. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03794.x · Cited by 249
In Vivo Association of E2F and DP Family Proteins
Wu, C.-L., Zukerberg, L. R., Ngwu, C., Harlow, E., & Lees, J. A. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2536 · Cited by 249
The CDK inhibitors in cancer research and therapy
Cicenas, J., & Valius, M. (2011) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-011-1039-4 · Cited by 243
Mechanisms of action of flavopiridol
Sedlacek, H. H. (2001) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00124-4 · Cited by 239
Regulation of CDK/cyclin complexes during the cell cycle
Arellano, M., & Moreno, S. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(96)00178-1 · Cited by 236
Variations in cyclin D1 levels through the cell cycle determine the proliferative fate of a cell
Yang, K., Hitomi, M., & Stacey, D. W. (2006) · Cell Division · doi:10.1186/1747-1028-1-32 · Cited by 233
Li, Y., Sun, X., LaMont, J. T., Pardee, A. B., & Li, C. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0538044100 · Cited by 231
Killing cells by targeting mitosis
Manchado, E., Guillamot, M., & Malumbres, M. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.197 · Cited by 228
Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation
Hydbring, P., Bahram, F., Su, Y., Tronnersjö, S., Högstrand, K., von der Lehr, N., Sharifi, H. R., Lilischkis, R., Hein, N., Wu, S., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900121106 · Cited by 225
Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27Kip1 and p21Cip1
Martín, A., Odajima, J., Hunt, S. L., Dubus, P., Ortega, S., Malumbres, M., & Barbacid, M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.05.006 · Cited by 223
Lin, T. S., Ruppert, A. S., Johnson, A. J., Fischer, B., Heerema, N. A., Andritsos, L. A., Blum, K. A., Flynn, J. M., Jones, J. A., Hu, W., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.6944 · Cited by 222
Targeting the cell division cycle in cancer: CDK and cell cycle checkpoint kinase inhibitors
COLLINS, I., & GARRETT, M. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.04.009 · Cited by 220
Structure-based design of a potent purine-based cyclin-dependent kinase inhibitor
Davies, T. G., Bentley, J., Arris, C. E., Boyle, F. T., Curtin, N. J., Endicott, J. A., Gibson, A. E., Golding, B. T., Griffin, R. J., Hardcastle, I. R., et al. (2002) · Nature Structural Biology · doi:10.1038/nsb842 · Cited by 219
The engine driving the ship: metabolic steering of cell proliferation and death
Buchakjian, M. R., & Kornbluth, S. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2972 · Cited by 219
Tong, W.-G., Chen, R., Plunkett, W., Siegel, D., Sinha, R., Harvey, R. D., Badros, A. Z., Popplewell, L., Coutre, S., Fox, J. A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.1347 · Cited by 215
Physiological Relevance of Cell Cycle Kinases
Malumbres, M. (2011) · Physiological Reviews · doi:10.1152/physrev.00025.2010 · Cited by 213
Manchado, E., Guillamot, M., de Cárcer, G., Eguren, M., Trickey, M., García-Higuera, I., Moreno, S., Yamano, H., Cañamero, M., & Malumbres, M. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.028 · Cited by 202
Raı̈s, B., Comin, B., Puigjaner, J., Brandes, J. L., Creppy, E., Saboureau, D., Ennamany, R., Paul Lee, W.-N., Boros, L. G., & Cascante, M. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00924-2 · Cited by 191
Self-citationCyclin D1 Determines Mitochondrial Function InVivo
Sakamaki, T., Casimiro, M. C., Ju, X., Quong, A. A., Katiyar, S., Liu, M., Jiao, X., Li, A., Zhang, X., Lu, Y., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02074-05 · Cited by 183
The effect of thiamine supplementation on tumour proliferation: A metabolic control analysis study
Comín‐Anduix, B., Boren, J., Martinez, S., Moro, C., Centelles, J. J., Trebukhina, R., Petushok, N., Lee, W. P., Boros, L. G., & Cascante, M. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02329.x · Cited by 181
Self-citationRegulation of Late G1/S Phase Transition and APCCdh1by Reactive Oxygen Species
Havens, C. G., Ho, A., Yoshioka, N., & Dowdy, S. F. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00303-06 · Cited by 180
Ludwig, H., Khayat, D., Giaccone, G., & Facon, T. (2005) · Cancer · doi:10.1002/cncr.21414 · Cited by 179
Menendez, J. A., Vellon, L., & Lupu, R. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi239 · Cited by 179
Switching cyclin D-Cdk4 kinase activity on and off
Blain, S. W. (2008) · Cell Cycle · doi:10.4161/cc.7.7.5637 · Cited by 178
Siemeister, G., Lücking, U., Wengner, A. M., Lienau, P., Steinke, W., Schatz, C. A., Mumberg, D., & Ziegelbauer, K. B. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0286 · Cited by 176
Colombo, S. L., Palacios-Callender, M., Frakich, N., Carcamo, S., Kovacs, I., Tudzarova, S., & Moncada, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117500108 · Cited by 172
Burton, J. L., & Solomon, M. J. (2001) · Genes & Development · doi:10.1101/gad.917901 · Cited by 172
Cyclin D1 and CDK4 Activity Contribute to the Undifferentiated Phenotype in Neuroblastoma
Molenaar, J. J., Ebus, M. E., Koster, J., Sluis, P. V., van Noesel, C. J. M., Versteeg, R., & Caron, H. N. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5032 · Cited by 171
Bcl-2 induces pro-oxidant state by engaging mitochondrial respiration in tumor cells
Chen, Z. X., & Pervaiz, S. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402165 · Cited by 170
miR-124, miR-137 and miR-340 regulate colorectal cancer growth via inhibition of the Warburg effect
SUN, Y., ZHAO, X., ZHOU, Y., & HU, Y. (2012) · Oncology Reports · doi:10.3892/or.2012.1958 · Cited by 169
Olmos, D., Barker, D., Sharma, R., Brunetto, A. T., Yap, T. A., Taegtmeyer, A. B., Barriuso, J., Medani, H., Degenhardt, Y. Y., Allred, A. J., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2946 · Cited by 169
Coy, J. F., Dressler, D., Wilde, J., & Schubert, P. (2005) · PubMed · Cited by 167
Almeida, A., Bolaños, J. P., & Moncada, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913668107 · Cited by 166
c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry
Morrish, F., Isern, N., Sadilek, M., Jeffrey, M., & Hockenbery, D. M. (2009) · Oncogene · doi:10.1038/onc.2009.112 · Cited by 164
Le Tourneau, C., Faivre, S., Laurence, V., Delbaldo, C., Vera, K., Girre, V., Chiao, J., Armour, S., Frame, S., Green, S. R., et al. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.08.001 · Cited by 163
Complexities in the development of cyclin-dependent kinase inhibitor drugs
Sausville, E. A. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02308-0 · Cited by 160
The oncogene c-Myc coordinates regulation of metabolic networks to enable rapid cell cycle entry
Morrish, F. M., Neretti, N., Sedivy, J. M., & Hockenbery, D. M. (2008) · Cell Cycle · doi:10.4161/cc.7.8.5739 · Cited by 158
Unrestricted cell cycling and cancer
Strauss, M., Lukas, J., & Bartek, J. (1995) · Nature Medicine · doi:10.1038/nm1295-1245 · Cited by 158
Viallard, J.-F., Lacombe, F., Belloc, F., Pellegrin, J., & Reiffers, J. J. (2001) · Cancer/Radiothérapie · doi:10.1016/s1278-3218(01)00087-7 · Cited by 155
Mice thrive without Cdk4 and Cdk2
Barrière, C., Santamaría, D., Cerqueira, A., Galán, J., Martín, A., Ortega, S., Malumbres, M., Dubus, P. R., & Barbacid, M. (2007) · Molecular Oncology · doi:10.1016/j.molonc.2007.03.001 · Cited by 152
Characterization of a Human Placental Fructose-6-Phosphate, 2-Kinase/Fructose- 2,6 - Bisphosphatase
Sakakibara, R., Kato, M., Okamura, N., Nakagawa, T., Komada, Y., Tominaga, N., Shimojo, M., & Fukasawa, M. (1997) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021719 · Cited by 152
Alessi, F., Quarta, S., Savio, M., Riva, F., Rossi, L. H., Stivala, L. A., Scovassi, A. I., Meijer, L., & Prosperi, E. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4216 · Cited by 152
RNA Polymerase II Carboxy-Terminal Domain Kinases: Emerging Clues to Their Function
Prelich, G. (2002) · Eukaryotic Cell · doi:10.1128/ec.1.2.153-162.2002 · Cited by 151
Xu, X., Hausen, A. Z., Coy, J. F., & Löchelt, M. (2008) · International Journal of Cancer · doi:10.1002/ijc.24078 · Cited by 151
Seguin, F., Carvalho, M. A., Bastos, D., Agostini, M., Zecchin, K. G., Alvarez-Flores, M. P., Chudzinski-Tavassi, A., Coletta, R. D., & Graner, E. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.355 · Cited by 148
Swinnen, J. V., Beckers, A., Brusselmans, K., Organe, S., Segers, J., Timmermans, L., Vanderhoydonc, F., Deboel, L., Derua, R., Waelkens, E., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3025 · Cited by 148
Cdk5 phosphorylates Cdh1 and modulates cyclin B1 stability in excitotoxicity
Maestre, C., Delgado‐Esteban, M., Sánchez, J. C. G., Bolaños, J. P., & Almeida, Á. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.195 · Cited by 144
Chen, H.-H., Wang, Y.-C., & Fann, M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.7.2736-2745.2006 · Cited by 144
Anaphase Inactivation of the Spindle Checkpoint
Palframan, W. J., Meehl, J. B., Jaspersen, S. L., Winey, M., & Murray, A. W. (2006) · Science · doi:10.1126/science.1127205 · Cited by 143
Colombo, S. L., Palacios‐Callender, M., Frakich, N., de León, J., Schmitt, C. A., Boorn, L., Davis, N., & Moncada, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012362107 · Cited by 139
Tudzarova, S., Colombo, S. L., Stoeber, K., Carcamo, S., Williams, G. H., & Moncada, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102247108 · Cited by 136
Brasca, M. G., Amboldi, N., Ballinari, D., Cameron, A. D., Casale, E., Cervi, G., Colombo, M., Colotta, F., Croci, V., D’Alessio, R., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9006559 · Cited by 130
Phosphorylation of E2F-1 by cyclin A-cdk2.
Kitagawa, M., Higashi, H., Suzuki‐Takahashi, I., Segawa, K., Sk, H., Taya, Y., Nishimura, S., & Okuyama, A. (1995) · PubMed · Cited by 130
Liu, B., Wang, Y., Fillgrove, K. L., & Anderson, V. E. (2002) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-001-0399-x · Cited by 129
Structure, function and mechanism of the anaphase promoting complex (APC/C)
Barford, D. (2010) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583510000259 · Cited by 129
p27Kip1 Metabolism: A Fascinating Labyrinth
Borriello, A., Cucciolla, V., Oliva, A., Zappia, V., & Ragione, F. D. (2007) · Cell Cycle · doi:10.4161/cc.6.9.4142 · Cited by 127
Lincet, H., Poulain, L., Rémy, J.-S., Deslandes, E., Duigou, F., Gauduchon, P., & Staedel, C. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00586-3 · Cited by 124
Burch, P. M., & Heintz, N. H. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.741 · Cited by 124
Ely, S. A., Liberto, M. D., Niesvizky, R., Baughn, L. B., Cho, H. J., Hatada, E. N., Knowles, D. M., Lane, J. M., & Chen‐Kiang, S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2159 · Cited by 124
Targeting Cell Division Cycle 7 Kinase: A New Approach for Cancer Therapy
Montagnoli, A., Moll, J. K., & Colotta, F. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0185 · Cited by 122
Löwenberg, B., Muus, P., Ossenkoppele, G. J., Rousselot, P. H., Cahn, J.-Y. Y., Ifrah, N., Martinelli, G., Amadori, S., Berman, E., Sonneveld, P., et al. (2011) · Blood · doi:10.1182/blood-2011-07-366930 · Cited by 121
A quantitative model for cyclin-dependent kinase control of the cell cycle: revisited
Uhlmann, F., Bouchoux, C., & López‐Avilés, S. (2011) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0082 · Cited by 121
A premature-termination mutation in the Mus musculus cyclin-dependent kinase 3 gene
Ye, X., Zhu, C., & Harper, J. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1682 · Cited by 119
Heath, E. I., Bible, K. C., Martell, R. E., Adelman, D. C., & LoRusso, P. M. (2007) · Investigational New Drugs · doi:10.1007/s10637-007-9090-3 · Cited by 114
Nuclear localization of Cdk5 is a key determinant in the postmitotic state of neurons
Zhang, J., Cicero, S. A., Wang, L., Romito-DiGiacomo, R. R., Yang, Y., & Herrup, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711355105 · Cited by 113
Hwang, J. H., Hwang, I., Liu, Q.-H., Woo, E., & Lee, D. G. (2012) · Biochimie · doi:10.1016/j.biochi.2012.04.010 · Cited by 112
Vizán, P., Alcarraz‐Vizán, G., Díaz‐Moralli, S., Solovjeva, O. N., Frederiks, W. M., & Cascante, M. (2009) · International Journal of Cancer · doi:10.1002/ijc.24262 · Cited by 110
Self-citationBurch, P. M., Yuan, Z., Loonen, A., & Heintz, N. H. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.11.4696-4709.2004 · Cited by 108
Is Cyclin D1-CDK4 kinase a bona fide cancer target?
Malumbres, M., & Barbacid, M. (2006) · Cancer Cell · doi:10.1016/j.ccr.2005.12.026 · Cited by 107
Zhou, C., Li, X., Sun, H., Zhang, B., Han, Y., Jiang, Y., Zhuang, Q., Fang, J. S., & Wu, G. (2012) · IUBMB Life · doi:10.1002/iub.1066 · Cited by 106
DePinto, W., Chu, X., Yin, X., Smith, M., Packman, K. E., Goelzer, P., Lovey, A. J., Chen, Y., Qian, H., Hamid, R., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0355 · Cited by 106
Redox modulation of the DNA damage response
Caputo, F., Vegliante, R., & Ghibelli, L. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.07.022 · Cited by 102
Johnson, A. J., Yeh, Y.-Y., Smith, L. L., Wagner, A. J., Hessler, J. D., Gupta, S. V., Flynn, J. M., Jones, J. A., Zhang, X., Bannerji, R., et al. (2012) · Leukemia · doi:10.1038/leu.2012.144 · Cited by 102
Proline dehydrogenase (oxidase) in cancer
Liu, W., & Phang, J. M. (2012) · BioFactors · doi:10.1002/biof.1036 · Cited by 99
Fulfilling the metabolic requirements for cell proliferation
Moncada, S., Higgs, E. A., & Colombo, S. L. (2012) · Biochemical Journal · doi:10.1042/bj20120427 · Cited by 99
Kang, K. H., Kim, W., & Choi, K. H. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4644 · Cited by 98
Chopin, V., Toillon, R., Jouy, N., & Bourhis, X. L. (2004) · Oncogene · doi:10.1038/sj.onc.1207020 · Cited by 98
The Krebs cycle meets the cell cycle: Mitochondria and the G 1 –S transition
Finkel, T., & Hwang, P. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906430106 · Cited by 97
Luke, J. J., D'Adamo, D. R., Dickson, M. A., Keohan, M. L., Carvajal, R. D., Maki, R. G., de Stanchina, E., Musi, E., Singer, S., & Schwartz, G. K. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3203 · Cited by 95
PF-03814735, an Orally Bioavailable Small Molecule Aurora Kinase Inhibitor for Cancer Therapy
Jani, J. P., Arcari, J. T., Bernardo, V., Bhattacharya, S. K., Briere, D. M., Cohen, B. D., Coleman, K. G., Christensen, J. G., Emerson, E. O., Jakowski, A. B., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0915 · Cited by 92
Gene silencing of TKTL1 by RNAi inhibits cell proliferation in human hepatoma cells
Zhang, S., Yang, J., Guo, C.-K., & Cai, P. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.01.010 · Cited by 91
Mandal, S., Freije, W. A., Guptan, P., & Banerjee, U. K. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.200912024 · Cited by 91
Mahadevan, D., Plummer, R., Squires, M. S., Rensvold, D., Kurtin, S. E., Pretzinger, C., Dragovich, T., Adams, J., Lock, V., Smith, D.-M., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq734 · Cited by 90
Frost, A., Mross, K. B., Steinbild, S., Hedbom, S., Unger, C., Kaiser, R., Trommeshauser, D., & Munzert, G. M. (2012) · Current Oncology · doi:10.3747/co.19.866 · Cited by 84
CDK13/CDC2L5 interacts with L-type cyclins and regulates alternative splicing
Chen, H.-H., Wong, Y., Genevière, A., & Fann, M. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.01.049 · Cited by 83
Talbot, D. C., von Pawel, J., Cattell, E., Yule, S. M., Johnston, C., Zandvliet, A. S., Huitema, A. D. R., Norbury, C. J., Ellis, P., Bosquée, L., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0249 · Cited by 83
Hikichi, Y., Honda, K., Hikami, K., Miyashita, H., Kaieda, I., Murai, S., Uchiyama, N., Hasegawa, M., Kawamoto, T., Sato, T., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0762 · Cited by 81
Cdc7 kinase – A new target for drug development
Swords, R. T., Mahalingam, D., O'Dwyer, M. E., Santocanale, C., Kelly, K. R., Carew, J. S., & Giles, F. J. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.09.020 · Cited by 79
Danusertib, an aurora kinase inhibitor
Meulenbeld, H. J., Mathijssen, R. H. J., Verweij, J., de Wit, R., & Jonge, M. J. D. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.652303 · Cited by 78
Deregulated CDC25A Expression Promotes Mammary Tumorigenesis with Genomic Instability
Ray, D., Terao, Y., Fuhrken, P. G., Ma, Z.-Q., DeMayo, F. J., Christov, K. T., Heerema, N. A., Franks, R. R., Tsai, S. Y., Papoutsakis, E. T., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3927 · Cited by 76
Cited by
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets
Feitelson, M. A., Arzumanyan, A., Kulathinal, R. J., Blain, S. W., Holcombe, R. F., Mahajna, J., Marino, M., Martinez-Chantar, M. L., Nawroth, R., Sanchez-Garcia, I., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.02.006 · Cited by 778
How the Warburg effect supports aggressiveness and drug resistance of cancer cells?
Icard, P., Shulman, S., Farhat, D., Steyaert, J.-M., Alifano, M., & Lincet, H. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.03.001 · Cited by 643
Arsenic exposure: A public health problem leading to several cancers
Palma-Lara, I., Martínez-Castillo, M., Quintana-Pérez, J. C., Arellano-Mendoza, M. G., Tamay-Cach, F., Valenzuela-Limón, O. L., García-Montalvo, E. A., & Hernández-Zavala, A. (2020) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2019.104539 · Cited by 473
Interconnection between Metabolism and Cell Cycle in Cancer
Icard, P., Fournel, L., Wu, Z., Alifano, M., & Lincet, H. (2019) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2018.12.007 · Cited by 327
Essential Oils and Their Constituents as Anticancer Agents: A Mechanistic View
Gautam, N., Mantha, A. K., & Mittal, S. (2014) · BioMed Research International · doi:10.1155/2014/154106 · Cited by 288
Metadata
- Authors
- Diaz-Moralli, S., Tarrado-Castellarnau, M., Miranda, A., & Cascante, M.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2013-05
- Volume
- 138
- Issue
- 2
- Pages
- 255-271
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W1976886432
- Cited by
- 361
- References
- 243
- FWCI
- 13.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.